pharmaceutical development

Submitted by [email protected] on Wed, 08/12/2020 - 12:00 PM

CARB-X is awarding up to US$2.91 million to Evotec SEa drug discovery and development company in Germany, to develop a new class of antibiotics to treat infections caused by deadly multidrug-resistant Gram-positive and Gram-negative bacteria.

Content Source: CARB-X

Content Author: CARB-X

Submitted by [email protected] on Thu, 07/30/2020 - 12:00 PM

Britain and India are expanding their existing scientific research collaboration with five new projects to tackle anti-microbial resistance (AMR) that could lead to important advances in the global fight against antibiotic-resistant bacteria and genes. The five projects are planned to start in September 2020. The UK is contributing £4 million from the UK Research and Innovation Fund for International Collaboration, and India is matching this with its own resources (£8 million in total). 

Content Source: United Kingdom

Content Author: United Kingdom

Submitted by [email protected] on Fri, 09/20/2019 - 12:00 PM

Dutch and US researchers have re-engineered non-druggable compounds that block the transmission and metabolism of the malaria parasite Plasmodium falciparum.

Content Source: European Biotechnology

Content Author: TG

Submitted by [email protected] on Thu, 07/25/2019 - 12:27 PM

Content Source: US Department of Health and Human Services (HHS)

Event Date:

Submitted by [email protected] on Thu, 05/02/2019 - 12:00 PM

Although new antibiotics are very much needed, they will only be most effective if they’re used sparingly — for the most critical of cases. This presents serious economic challenges to developing antibiotics.

Content Source: STAT

Content Author: Meghan Keshavan

Submitted by [email protected] on Thu, 03/07/2019 - 12:00 PM

The development and ultimate approval of tecovirimat for the antiviral treatment of smallpox, a disease that has been eradicated from the world for nearly 40 years, required a unique regulatory approach based on the US Food and Drug Administration's Animal Rule.

Content Source: Lancet

Content Author: Kirk M Chan-Tack, Patrick R Harrington, Su-Young Choi

Submitted by [email protected] on Wed, 02/06/2019 - 08:50 AM

Content Source: SMI Group

Event Date:

Submitted by [email protected] on Mon, 01/14/2019 - 12:00 PM

Using computer modelling, researchers were able to identify new drugs by building a reliable replica of the bacterial protein and then working out what the best orientation is for the drug to fit in the bacterial protein.

Content Source: MedicalXpress

Content Author: Ruben Cloete

Submitted by [email protected] on Thu, 11/29/2018 - 08:48 AM

Content Source: Wellcome Centre for Anti-Infectives Research

Event Date:

Submitted by [email protected] on Fri, 10/12/2018 - 12:00 PM

Accepting that antibiotics are infrastructure would change our relationship to the drugs, forcing us to recognize that medicine requires long-term planning.

Content Source: Wired

Content Author: Maryn McKenna